Ilya Chumakov
85Patents
15h-index
25Co-inventors
84Inventor score
Filing activity: Dec 22, 1997 → Mar 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6258571A | High throughput DNA sequencing vector | Chemistry; Metallurgy | 103 | Expired |
| US6528260B1 | Biallelic markers related to genes involved in drug metabolism | Chemistry; Metallurgy | 38 | Expired |
| US6346381B1 | Prostate cancer gene | Chemistry; Metallurgy | 27 | Expired |
| US6531279B1 | Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma | Chemistry; Metallurgy | 23 | Expired |
| US6537751B1 | Biallelic markers for use in constructing a high density disequilibrium map of the human genome | Chemistry; Metallurgy | 22 | Expired |
| US6544737B1 | Genomic sequence of the purH gene and purH-related biallelic markers | Physics | 21 | Expired |
| US6265546A | Prostate cancer gene | Chemistry; Metallurgy | 20 | Expired |
| US8716269B2 | Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders | Human Necessities | 19 | Active |
| US6432648B1 | Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism | Physics | 19 | Expired |
| US6476208B1 | Schizophrenia associated genes, proteins and biallelic markers | Chemistry; Metallurgy | 19 | Expired |
| US8992891B2 | Therapeutic approaches for treating CMT and related disorders | Human Necessities | 18 | Active |
| US8741886B2 | Baclofen and acamprosate based therapy of neurological disorders | Human Necessities | 17 | Active |
| US5945522A | Prostate cancer gene | Chemistry; Metallurgy | 17 | Expired |
| US7118869B2 | Genomic sequence of the 5-Lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma | Chemistry; Metallurgy | 16 | Expired |
| US9241933B2 | Compositions for treating amyotrophic lateral sclerosis | Human Necessities | 15 | Active |
| US6955902B2 | High throughput DNA sequencing vector | Chemistry; Metallurgy | 15 | Expired |
| US9427436B1 | Compositions for treating CMT and related disorders | Human Necessities | 13 | Active |
| US9393241B2 | Compositions for treating CMT and related disorders | Human Necessities | 13 | Active |
| US9566275B2 | Compositions for treating CMT and related disorders | Human Necessities | 13 | Active |
| US8865769B2 | Baclofen and acamprosate based therapy of neurological disorders | Human Necessities | 13 | Active |
| US8809302B2 | Therapeutic approaches for treating alzheimer'S disease | Human Necessities | 12 | Active |
| US6555316B1 | Schizophrenia associated gene, proteins and biallelic markers | Chemistry; Metallurgy | 10 | Expired |
| US6329340A | Human Defensin DEF-X | Physics | 7 | Expired |
| US9144558B2 | Baclofen and acamprosate based therapy of neurological disorders | Human Necessities | 6 | Active |
| US9248111B2 | Therapeutic approaches for treating parkinson's disease | Human Necessities | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.